Raltegravir is an antiretroviral medication used to treat HIV/AIDS. Raltegravir manufacturers market both the standalone version as well as a combination formulation (along with lamivudine) of the drug. They are available under the trade names Isentress and Dutrebis respectively. Suppliers of raltegravir-inclusive medications distribute it in tablet form. The developer and earliest manufacturer of raltegravir is Merck, who first made it available in 2007, making it the first-ever integrase inhibitor class drug to be marketed globally. Isentress is currently approved in over 100 countries, including but not limited to such geographic markets as China, Australia, Argentina, Singapore and South Africa. It has also become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Given that Merck’s patent is still valid, no other generic or trade name variants of the drug have as of yet been introduced into the global raltegravir market by other manufacturers.

It acts by lowering the level of HIV in the blood. Although raltegravir does not treat HIV, it may lessen your risk of getting AIDS and other diseases connected to HIV, such as severe conditions or cancer. To stop the viral genome from being integrated into the human genome, raltegravir inhibits the HIV integrase enzyme. Glucuronidation is the main mode of metabolism for raltegravir. 83 percent of it is linked to human plasma protein and only a small amount gets into red blood cells. In humans, glucuronidation, which is mediated by UGT1A1, is the main mechanism of raltegravir clearance. Renal clearance of the drug in its unchanged form is a minor route of raltegravir elimination.

Raltegravir is a relatively costly drug. 60 (400mg) tablets of it are priced at around 650 EUR. Pharmaceutical specialists are welcome to browse through offers of raltegravir tablets from suppliers on our pharmaceutical marketplace, or else seek out further useful medical information about raltegravir online. The price of Raltegravir is higher than that of such substitutes, owing largely to the more costly manufacturing process needed to produce it. Also, the costs of Raltegravir vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. It is available or sale at every medical store. Raltegravir suppliers, on the whole, are in favor of patient aid initiatives. Raltegravir is available for sale from various Raltegravir vendors at multiple costs.

Pharmaceutical specialists are welcome to browse through offers of Raltegravir capsules, injectable solutions, and oral solutions from suppliers in our B2B pharmaceutical marketplace, or else find more information about Raltegravir online at the official Epilepsy Foundation website. Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to Raltegravir manufacturers and suppliers. Finding reliable suppliers and manufacturers of particular medications like Raltegravir can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Raltegravir suppliers or manufacturers. You may also use filters to narrow down your search results and look for Raltegravir from particular nations.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Raltegravir offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Raltegravir suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Raltegravir. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Raltegravir is already registered. Manufacturers also have special delivery terms.

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Raltegravir suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Raltegravir manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.